Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular versus intravenous naloxone for methadone overdose
IRCT20120629010133N6Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of naloxone in methadone intoxication and opioid intoxication (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Re-narcosis, Withdrawal syndrome and 2 more. Started Jan 2023; status: completed.
02
Drugs
naloxone
03
Conditions
methadone intoxicationopioid intoxication
Beyond the preview
Go deeper on IRCT20120629010133N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120629010133N6.